These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. FDA notifications. Enfuvirtide has new instructions. AIDS Alert; 2007 Apr; 22(4):44-5. PubMed ID: 17595723 [No Abstract] [Full Text] [Related]
44. Emerging drugs in the fight against HIV disease. Rosenthal E HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497 [No Abstract] [Full Text] [Related]
45. Enfuvirtide beneficial in experienced patients. AIDS Patient Care STDS; 2004 Jan; 18(1):57. PubMed ID: 15080095 [No Abstract] [Full Text] [Related]
46. Recent FDA approvals and changes. AIDS Patient Care STDS; 2010 Oct; 24(10):684. PubMed ID: 20929413 [No Abstract] [Full Text] [Related]
47. HIV-1 coreceptor use in triple-class treatment-experienced patients: baseline prevalence, correlates, and relationship to enfuvirtide response. Melby T; Despirito M; Demasi R; Heilek-Snyder G; Greenberg ML; Graham N J Infect Dis; 2006 Jul; 194(2):238-46. PubMed ID: 16779731 [TBL] [Abstract][Full Text] [Related]
48. 3TC receives full approval. Grodeck B; Vazquez E Posit Aware; 1997; 8(3):11. PubMed ID: 11364417 [TBL] [Abstract][Full Text] [Related]
49. HIV medicine after Barcelona conference: interview with Howard Grossman, M.D. Interview by John S. James. Grossman H AIDS Treat News; 2002 Sep; (383):2-7. PubMed ID: 12765126 [TBL] [Abstract][Full Text] [Related]